News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
100,908 Results
Type
Article (7942)
Company Profile (40)
Press Release (92926)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (29451)
Career Advice (454)
Deals (4294)
Drug Delivery (33)
Drug Development (14637)
Employer Resources (27)
FDA (3089)
Job Trends (2343)
News (52384)
Policy (6390)
Tag
Academia (495)
Accelerated approval (3)
Adcomms (7)
Allergies (33)
Alliances (9377)
ALS (13)
Alzheimer's disease (282)
Antibody-drug conjugate (ADC) (49)
Approvals (3079)
Artificial intelligence (52)
Autoimmune disease (10)
Automation (3)
Bankruptcy (21)
Best Places to Work (1963)
BIOSECURE Act (16)
Biosimilars (78)
Biotechnology (26)
Bladder cancer (27)
Brain cancer (7)
Breast cancer (56)
Cancer (517)
Cardiovascular disease (25)
Career advice (377)
Career pathing (3)
CAR-T (23)
Cell therapy (90)
Cervical cancer (4)
Clinical research (11964)
Collaboration (204)
Compensation (48)
Complete response letters (9)
COVID-19 (591)
CRISPR (6)
C-suite (60)
Cystic fibrosis (13)
Data (502)
Denatured (4)
Depression (7)
Diabetes (41)
Diagnostics (616)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (28)
Drug pricing (29)
Drug shortages (1)
Duchenne muscular dystrophy (29)
Earnings (10137)
Editorial (9)
Employer branding (4)
Employer resources (22)
Events (12607)
Executive appointments (130)
FDA (3487)
Frontotemporal dementia (2)
Funding (160)
Gene editing (26)
Generative AI (7)
Gene therapy (96)
GLP-1 (120)
Government (1394)
Grass and pollen (1)
Guidances (36)
Healthcare (2215)
Huntington's disease (4)
IgA nephropathy (3)
Immunology and inflammation (48)
Indications (10)
Infectious disease (628)
Inflammatory bowel disease (53)
Inflation Reduction Act (4)
Influenza (16)
Intellectual property (12)
Interviews (97)
IPO (1958)
IRA (14)
Job creations (447)
Job search strategy (320)
Kidney cancer (2)
Labor market (3)
Layoffs (66)
Leadership (5)
Legal (644)
Liver cancer (15)
Lung cancer (81)
Lymphoma (33)
Machine learning (2)
Management (7)
Manufacturing (124)
MASH (15)
Medical device (1439)
Medtech (1440)
Mergers & acquisitions (2442)
Metabolic disorders (100)
Multiple sclerosis (19)
NASH (2)
Neurodegenerative disease (19)
Neuropsychiatric disorders (1)
Neuroscience (367)
NextGen: Class of 2025 (833)
Non-profit (449)
Now hiring (11)
Obesity (38)
Opinion (79)
Ovarian cancer (24)
Pain (10)
Pancreatic cancer (14)
Parkinson's disease (9)
Partnered (3)
Patents (32)
Patient recruitment (22)
Peanut (21)
People (8627)
Pharmaceutical (12)
Pharmacy benefit managers (4)
Phase I (3885)
Phase II (4999)
Phase III (4401)
Pipeline (371)
Policy (62)
Postmarket research (326)
Preclinical (1541)
Press Release (66)
Prostate cancer (19)
Psychedelics (5)
Radiopharmaceuticals (39)
Rare diseases (73)
Real estate (999)
Recruiting (12)
Regulatory (5047)
Reports (12)
Research institute (429)
Resumes & cover letters (60)
RNA editing (1)
RSV (11)
Schizophrenia (13)
Series A (37)
Series B (14)
Service/supplier (3)
Sickle cell disease (7)
Special edition (4)
Spinal muscular atrophy (22)
Sponsored (9)
Startups (629)
State (1)
Stomach cancer (3)
Supply chain (11)
Tariffs (13)
The Weekly (5)
Vaccines (202)
Venture capitalists (6)
Weight loss (20)
Women's health (4)
Worklife (1)
Date
Today (12)
Last 7 days (192)
Last 30 days (602)
Last 365 days (6391)
2025 (2416)
2024 (6741)
2023 (7245)
2022 (9566)
2021 (9990)
2020 (8758)
2019 (6534)
2018 (5042)
2017 (5461)
2016 (5055)
2015 (5700)
2014 (4084)
2013 (3194)
2012 (3323)
2011 (3514)
2010 (2870)
Location
Africa (154)
Alabama (12)
Alaska (2)
Arizona (19)
Arkansas (2)
Asia (7908)
Australia (1012)
California (1266)
Canada (287)
China (184)
Colorado (35)
Connecticut (29)
Delaware (50)
Europe (14898)
Florida (159)
Georgia (19)
Idaho (15)
Illinois (64)
India (12)
Indiana (41)
Iowa (2)
Japan (31)
Kansas (4)
Kentucky (9)
Louisiana (2)
Maine (5)
Maryland (330)
Massachusetts (882)
Michigan (54)
Minnesota (60)
Mississippi (1)
Missouri (17)
Montana (5)
Nebraska (1)
Nevada (4)
New Hampshire (3)
New Jersey (483)
New Mexico (4)
New York (373)
North Carolina (208)
North Dakota (8)
Northern California (534)
Ohio (43)
Oklahoma (7)
Oregon (6)
Pennsylvania (205)
Puerto Rico (1)
Rhode Island (5)
South America (230)
South Carolina (2)
Southern California (538)
Tennessee (3)
Texas (168)
United States (4617)
Utah (27)
Virginia (20)
Washington D.C. (7)
Washington State (104)
Wisconsin (9)
100,908 Results for "sound biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
Former FDA Officials Sound Alarm: Visible Changes May Be ‘Tip of the Iceberg’
In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER director spoke to analysts about potential implications for drug review timelines and agency morale.
April 16, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Sound Pharma to Present at Upcoming Life Science Investor Conferences
April 8, 2025
·
2 min read
BioForest
Sound Pharmaceuticals’ IND Involving Cochlear Implantation Allowed by the FDA
Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI).
May 20, 2024
·
3 min read
Press Releases
Sound Blade Medical Closes $16.5 Million Series A Financing to Advance the Development of Innovative Handheld Histotripsy Therapy
January 30, 2025
·
2 min read
BioMidwest
NephroDI Therapeutics Announces Investment by Sound Bioventures to Accelerate Development of NDI-5001 as a Potential First-in-Class Therapy for Pediatric Orphan Kidney Disease
NephroDI Therapeutics (NephroDI), a near-clinical stage pharmaceutical company focusing on kidney disorders, announces a Series A investment from life sciences VC Sound Bioventures.
June 20, 2024
·
4 min read
Sound Bioventures joins £19M ($24.5M) financing in UK oncolytic virus company Theolytics
Sound Bioventures announced a new investment in Theolytics, a UK biotechnology company developing next-generation oncolytic viral therapies.
April 17, 2024
·
4 min read
Press Releases
Sound Pharma to Present SPI-1005 Preclinical and Clinical Hearing Loss and Tinnitus Data at the Defense Health Agency Hearing Center of Excellence Symposia and ARO MWM
February 18, 2025
·
3 min read
Press Releases
Sound Pharma Announces Positive Phase 3 Results for the Treatment of Meniere’s Disease with SPI-1005
December 10, 2024
·
5 min read
Hanvon Technology Launches Groundbreaking Fourth-Generation BP Meter Based on Korotkoff Sound Method
Hanvon Technology Co., Ltd., based in China, has launched the world’s first smart electronic BP Meter utilizing the Korotkoff sound method.
February 29, 2024
·
2 min read
Theolytics successfully closes latest financing raising total of £19M ($24.5M) and welcomes Sound Bioventures as new investor
Theolytics, a biotechnology company developing next-generation oncolytic viral therapies, announced it has successfully closed its latest financing round, raising a total of £19M with the addition of Sound Bioventures as a new investor.
April 17, 2024
·
4 min read
1 of 10,091
Next
